ZIPEXOLE pramipexole dihydrochloride 1.5 mg tablets blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

pramipexole dihydrochloride monohydrate, Quantity: 1.5 mg

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

Designació comuna internacional (DCI):

pramipexole dihydrochloride monohydrate

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: silicon dioxide; povidone; mannitol; pregelatinised maize starch; magnesium stearate

Vía de administración:

Oral

Unidades en paquete:

10, 30, 100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Resumen del producto:

Visual Identification: White, circular, flat, beveled edged, uncoated tablets debossed with 'CL' and '6' debossed on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-09-23